Table 3. ORs of Outcomes in LCR Groups on Day 1 and Day 7 of Treatment.
| Outcomes | Day 1 |
Day 7 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | LCR < 100 | LCR > 101 | Unadjusted odds (P value) | aOR (P value) | N | LCR < 100 | LCR > 101 | Unadjusted odds (P value) | aOR (P value) | |
| Vent | 60 | 17 (28%) | 43 (72%) | OR 2.5 (1.3 - 5.0, P = 0.01) | aOR 2.5 (1.3 - 5.0, P = 0.009) | 56 | 12 (21%) | 44 (78%) | OR 1.8 (0.8 - 4.0, P = 0.21) | aOR 1.06 (0.43 - 2.64, P = 0.89) |
| No vent | 110 | 55 (50%) | 55 (50%) | 76 | 25 (33%) | 51 (68%) | ||||
| Upgrade | 55 | 14 (26%) | 41 (75%) | OR 2.9 (1.47 - 6.1, P = 0.004) | aOR 3.1 (1.5 - 6.3, P = 0.003) | 50 | 10 (20%) | 40 (80%) | OR 2.0 (0.9 - 5.0, P = 0.16) | aOR 1.16 (0.46 - 2.96, P = 0.74) |
| No upgrade | 115 | 58 (50%) | 57 (50%) | 82 | 27 (33%) | 55 (67%) | ||||
| Dialysis | 10 | 3 (30%) | 7 (70%) | OR 1.8 (0.4 - 7.1, P = 0.63) | aOR 1.8 (0.4 - 8.0, P = 0.44) | 7 | 1 (14%) | 6 (86%) | OR 2.4 (0.3 - 21.0, P = 0.70) | aOR 3.7 (0.2 - 55.6, P = 0.34) |
| No dialysis | 160 | 69 (43%) | 91 (57%) | 125 | 36 (29%) | 89 (71%) | ||||
| Died | 20 | 10 (50%) | 10 (50%) | OR 0.71 (0.3 - 1.8, P = 0.62) | aOR 0.8 (0.3 - 2.0, P = 0.60) | 19 | 12 (63%) | 7 (37%) | OR 0.2 (0.06 - 0.47, P = 0.001) | aOR 0.1 (0.01 - 0.30, P < 0.0001) |
| Alive | 150 | 62 (41%) | 88 (58%) | 113 | 25 (22%) | 88 (78%) | ||||
aOR: adjusted odds ratio; OR: odds ratio; LCR: lymphocyte-to-C-reactive protein ratio.